15-67066040-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_005902.4(SMAD3):c.-115C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000439 in 546,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
SMAD3
NM_005902.4 5_prime_UTR
NM_005902.4 5_prime_UTR
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.64
Publications
0 publications found
Genes affected
SMAD3 (HGNC:6769): (SMAD family member 3) The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. This protein forms a complex with other SMAD proteins and binds DNA, functioning both as a transcription factor and tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, May 2022]
SMAD3 Gene-Disease associations (from GenCC):
- aneurysm-osteoarthritis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 15-67066040-C-T is Benign according to our data. Variant chr15-67066040-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 316858.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000113 (17/150578) while in subpopulation EAS AF = 0.00299 (15/5024). AF 95% confidence interval is 0.00184. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAD3 | NM_005902.4 | c.-115C>T | 5_prime_UTR_variant | Exon 1 of 9 | ENST00000327367.9 | NP_005893.1 | ||
SMAD3 | NM_001407011.1 | c.-115C>T | 5_prime_UTR_variant | Exon 1 of 10 | NP_001393940.1 | |||
SMAD3 | NM_001407012.1 | c.-115C>T | 5_prime_UTR_variant | Exon 1 of 8 | NP_001393941.1 | |||
SMAD3 | NM_001407013.1 | c.-115C>T | 5_prime_UTR_variant | Exon 1 of 8 | NP_001393942.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000113 AC: 17AN: 150468Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
17
AN:
150468
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000177 AC: 7AN: 396420Hom.: 0 Cov.: 6 AF XY: 0.0000147 AC XY: 3AN XY: 204344 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
396420
Hom.:
Cov.:
6
AF XY:
AC XY:
3
AN XY:
204344
show subpopulations
African (AFR)
AF:
AC:
0
AN:
8284
American (AMR)
AF:
AC:
0
AN:
6114
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
9060
East Asian (EAS)
AF:
AC:
3
AN:
20582
South Asian (SAS)
AF:
AC:
0
AN:
15802
European-Finnish (FIN)
AF:
AC:
0
AN:
23522
Middle Eastern (MID)
AF:
AC:
0
AN:
1524
European-Non Finnish (NFE)
AF:
AC:
2
AN:
291166
Other (OTH)
AF:
AC:
2
AN:
20366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000113 AC: 17AN: 150578Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 9AN XY: 73600 show subpopulations
GnomAD4 genome
AF:
AC:
17
AN:
150578
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
73600
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41282
American (AMR)
AF:
AC:
0
AN:
15176
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3454
East Asian (EAS)
AF:
AC:
15
AN:
5024
South Asian (SAS)
AF:
AC:
2
AN:
4804
European-Finnish (FIN)
AF:
AC:
0
AN:
10086
Middle Eastern (MID)
AF:
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67470
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.